XML 24 R17.htm IDEA: XBRL DOCUMENT v3.2.0.727
RESEARCH AND LICENSE AGREEMENT (Details Textual) - 6 months ended Jun. 30, 2015
Total
Research And License Agreement [Line Items]  
Percentage Of Royalty Payment If Licensed Product Covered By Valid Claim Or Orphan Drug Status 5.00%
Percentage Of Royalty Payment If Licensed Product Not Covered By Valid Claim Or Orphan Drug Status 3.00%
Validity Of Royalty Payment Not Covered By Valid Claim Or Orphan Drug Status 15 years